ZA976807B - Amino acid compositions and use thereof in immunosuppression - Google Patents

Amino acid compositions and use thereof in immunosuppression

Info

Publication number
ZA976807B
ZA976807B ZA976807A ZA976807A ZA976807B ZA 976807 B ZA976807 B ZA 976807B ZA 976807 A ZA976807 A ZA 976807A ZA 976807 A ZA976807 A ZA 976807A ZA 976807 B ZA976807 B ZA 976807B
Authority
ZA
South Africa
Prior art keywords
immunosuppression
amino acid
acid compositions
compositions
amino
Prior art date
Application number
ZA976807A
Other languages
English (en)
Inventor
Heinz Schneider
Original Assignee
Novartis Nutrition Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Nutrition Ag filed Critical Novartis Nutrition Ag
Publication of ZA976807B publication Critical patent/ZA976807B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA976807A 1996-07-30 1997-07-30 Amino acid compositions and use thereof in immunosuppression ZA976807B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/690,476 US6096785A (en) 1996-07-30 1996-07-30 Amino acid compositions and use thereof in treating renal dysfunction

Publications (1)

Publication Number Publication Date
ZA976807B true ZA976807B (en) 1999-02-01

Family

ID=24772611

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA976807A ZA976807B (en) 1996-07-30 1997-07-30 Amino acid compositions and use thereof in immunosuppression

Country Status (17)

Country Link
US (2) US6096785A (xx)
EP (1) EP0952827A1 (xx)
JP (1) JP4199308B2 (xx)
KR (1) KR20000029698A (xx)
CN (1) CN1146414C (xx)
AU (1) AU722442B2 (xx)
CA (1) CA2260956A1 (xx)
CZ (1) CZ31299A3 (xx)
ID (1) ID19428A (xx)
IL (1) IL127907A0 (xx)
MY (1) MY124560A (xx)
NO (1) NO325946B1 (xx)
PL (1) PL331355A1 (xx)
RU (1) RU2219925C2 (xx)
SK (1) SK11399A3 (xx)
WO (1) WO1998004256A1 (xx)
ZA (1) ZA976807B (xx)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9701674D0 (en) * 1997-01-28 1997-03-19 Novartis Nutrition Ag Use of organic compounds
US6281244B1 (en) * 1997-06-05 2001-08-28 Novartis Nutrition Ag Therapeutic use for glycine
ES2221095T3 (es) * 1997-06-05 2004-12-16 Novartis Nutrition Ag Glicina para prevencion o tratamiento del rechazo de transplantes.
US6288116B1 (en) * 1998-05-13 2001-09-11 Novartis Nutrition Ag Method of administration of a nutritional product to a person having renal failure
US20070032853A1 (en) 2002-03-27 2007-02-08 Hossainy Syed F 40-O-(2-hydroxy)ethyl-rapamycin coated stent
EP1174143B1 (en) * 2000-07-14 2004-06-02 HealthEcon AG Green tea extract and use thereof in treating renal dysfunction induced by cyclosporins or ascomycins
US6864242B2 (en) * 2001-03-05 2005-03-08 Stephen P. Ernest Enteral formulation
US20050118344A1 (en) 2003-12-01 2005-06-02 Pacetti Stephen D. Temperature controlled crimping
US20060281642A1 (en) * 2005-05-18 2006-12-14 David Colbourne Lubricating oil composition and use thereof
SG193246A1 (en) * 2011-03-31 2013-10-30 Nestec Sa Nutritional compositions for increasing arginine levels and methods of using same
BR112013026032A2 (pt) * 2011-04-12 2016-12-20 Nestec Sa composições nutricionais incluindo ácidos graxos de cadeia ramificada para cicatrização de ferida
JOP20190146A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
EP3668499A1 (en) 2017-08-14 2020-06-24 Axcella Health Inc. Amino acid compositions for the treatment of liver disease
EP3810123A1 (en) 2018-06-20 2021-04-28 Axcella Health Inc. Compositions and methods for the treatment of fat infiltration in muscle

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5290538A (en) * 1988-12-22 1994-03-01 Skrezek Christian Nephro protective infusion solutions
US5576287A (en) * 1994-04-29 1996-11-19 Wake Forest University Method for treating acute renal disease and failure
JPH11501301A (ja) * 1995-02-23 1999-02-02 ノバルティス・ニュートリション・アクチエンゲゼルシャフト アミノ酸組成物および臨床的栄養補給におけるその使用
US5656608B1 (en) * 1995-02-23 2000-09-26 Novartis Nutrition Ltd Amino acid compositions and methods of treatment using same

Also Published As

Publication number Publication date
CN1226827A (zh) 1999-08-25
JP4199308B2 (ja) 2008-12-17
KR20000029698A (ko) 2000-05-25
NO325946B1 (no) 2008-08-25
CA2260956A1 (en) 1998-02-05
CZ31299A3 (cs) 1999-05-12
NO990373L (no) 1999-01-27
ID19428A (id) 1998-07-09
NO990373D0 (no) 1999-01-27
IL127907A0 (en) 1999-11-30
AU3771697A (en) 1998-02-20
US6096785A (en) 2000-08-01
SK11399A3 (en) 1999-09-10
PL331355A1 (en) 1999-07-05
AU722442B2 (en) 2000-08-03
CN1146414C (zh) 2004-04-21
JP2000515875A (ja) 2000-11-28
RU2219925C2 (ru) 2003-12-27
MY124560A (en) 2006-06-30
WO1998004256A1 (en) 1998-02-05
US6204244B1 (en) 2001-03-20
EP0952827A1 (en) 1999-11-03

Similar Documents

Publication Publication Date Title
HUP0102900A3 (en) Improved solid-phase peptide synthesis and agent for use in such synthesis
AU4484997A (en) Compositions containing cobalamin and amino acids
PL344589A1 (en) COMPOSITION COMPRISING β-HYDROXY-β-METHYLBUTYRIC ACID AND AT LEAST ONE AMINO ACID AND METHODS OF USE
HUP0000302A3 (en) Ob fusion protein compositions and methods
AU6990796A (en) Synthetic peptides and their use in cosmetic or dermopharmaceutical compositions
GB9700558D0 (en) Improvements in and relating to surfaces
ZA976807B (en) Amino acid compositions and use thereof in immunosuppression
GB9717598D0 (en) Novel composition and use
EP1080182A4 (en) AMINO ACID MODIFIED POLYPEPTIDES
GB9624159D0 (en) Improvements in or relating to contact lens cases and use thereof
GB9601638D0 (en) Improvements in and relating to balls
GB9608505D0 (en) Compositions processes and uses
GB9709318D0 (en) Improvements in and relating to anti-photocopying measures
GB9718636D0 (en) Novel composition and use
GB2314250B (en) Improvements in and relating to sheep handling
GB9625124D0 (en) Improvements in and relating to identification
GB2314792B (en) Improvements in and relating to screwdrivers
GB2318687B (en) Improvements in and relating to consumer units
GB9722392D0 (en) Composition and use
GB9710389D0 (en) Improvements in or relating to solids - emulating compositions and to burnishing devices
GB9624161D0 (en) Improvements in or relating to contact lens cases and use thereof
ZA945197B (en) Amino acid composition
GB9711592D0 (en) Improvements in and relating to lacquers
GB9610115D0 (en) Improvements in and relating to elements
GB9604426D0 (en) Pharmaceutical composition and use thereof